Structure-based virtual screening and Molecular Dynamic Simulations identified FDA-approved molecules as potential inhibitors against the surface proteins of H1N1
Sukanya Bordoloi, Roshny Prasad, VS Lakshmi, Rajesh Chandramohanadas, Kathiresan Natarajan, Shijulal Nelson Sathi
The paper identifies FDA-approved molecules as potential inhibitors of H1N1 viral surface proteins through virtual screening and molecular dynamics simulations.
bioRxiv · Dec 2, 2023 · PreprintBioinformatics